Long-term functional prognosis with tocilizumab in severe COVID-19 infection: A multicenter prospective observational study on mechanically ventilated ICU patients in the COVID-19 recovery study II

Junji Hatakeyama(Osaka University of Pharmaceutical Sciences), Hiroyasu Iso(University of Tsukuba), Arisa Iba(National Center for Global Health and Medicine), Yoko Muto(National Center for Global Health and Medicine), Naoki Kanda(Jichi Medical University), Akira Kawauchi(Maebashi Red Cross Hospital), Mariko Hosozawa(National Center for Global Health and Medicine), Kensuke Nakamura(Hitachi General Hospital), Hiroshi Kamijo(Shinshu University Hospital), Hideaki Kato(Yokohama City University Hospital), Kohei Ota(Hiroshima University), Miyuki Hori(Public Health Department), Shigeki Fujitani(St. Marianna University School of Medicine), Tomohiro Asahi(Naha City Hospital), Taku Oshima(Chiba University)
Journal of Infection and Chemotherapy
April 17, 2025
Cited by 1


Related Papers